United BioSource LLC has acquired Vancouver-based Evidinno Outcomes Research Inc., a move that sharply expands its ...

The INSPIRE Trial Prospectively Assesses Pulse Oximeter Accuracy Using a Unique Real-world Study Design and in the Feasibility Study Showed No Clinically Significant Bias Between Patients with Light ...

A new report by HEPI and Taylor & Francis explores the potential of AI to advance translational research and accelerate the ...

The foundational design partnership applies structured AI reasoning in high-stakes, regulated environments, with detailed ...

A minimally invasive surgical procedure for glaucoma designed to reduce intraocular pressure (IOP) has been found to have a high degree of success and significantly reduce the use of drugs for the ...

The rise in direct-to-patient therapeutics access via online compounding pharmacies and other direct-to-patient sales models has increased the likelihood of patients utilizing medications alongside ...

Cardiovascular disease still claims more lives than any other illness, and many adults living with obesity or type 2 diabetes carry a heavy risk of heart attack and stroke. Two medications, ...

Ruxolitinib cream shows rapid, significant repigmentation in NSV, aligning with phase 3 trial outcomes and suggesting first-line therapy potential, especially for facial involvement. The study's ...

In Feasibility Study for Large, Prospective, Real-World Trial, Masimo SET® Performed Accurately on Critically Ill Adult ICU Patients of All Skin Tones The INSPIRE Trial Prospectively Assesses Pulse ...